With new approaches to therapy and increased understanding of the biology of cancer, breast cancer treatment has made significant progress in recent years.
“I am personally very excited about what’s to come for breast cancer treatment,” says Eric Winer, MD, director of the Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers at Dana-Farber. “I think we will have drugs available in the clinic in the next several years that may have a dramatic impact on outcomes for women with breast cancer.”
Winer discussed the latest in breast cancer treatment and research during a live video webchat hosted by Dana-Farber last month. The chat, which featured questions submitted by patients and caregivers, covered topics on tamoxifen, aromatase inhibitors, and new treatment options for HER2-postiive and triple-negative breast cancers.
View a video of the May 22 webchat below. For more information on breast cancer, visit the website for the Susan F. Smith Center’s Breast Oncology Program.